124 related articles for article (PubMed ID: 33323685)
1. The association of transporter ABCC2 (MRP2) genetic variation and drug-induced hyperbilirubinemia.
Huang YS; Chang TE; Perng CL; Huang YH
J Chin Med Assoc; 2021 Feb; 84(2):129-135. PubMed ID: 33323685
[TBL] [Abstract][Full Text] [Related]
2. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
[TBL] [Abstract][Full Text] [Related]
3. Selected ABCB1, ABCB4 and ABCC2 polymorphisms do not enhance the risk of drug-induced hepatotoxicity in a Spanish cohort.
Ulzurrun E; Stephens C; Ruiz-Cabello F; Robles-Diaz M; Saenz-López P; Hallal H; Soriano G; Roman E; Fernandez MC; Lucena MI; Andrade RJ
PLoS One; 2014; 9(4):e94675. PubMed ID: 24732756
[TBL] [Abstract][Full Text] [Related]
4. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population.
Xue T; Lu ZN
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27886333
[TBL] [Abstract][Full Text] [Related]
5. Alterations of canalicular ATP-binding cassette transporter expression in drug-induced liver injury.
Zollner G; Thueringer A; Lackner C; Fickert P; Trauner M
Digestion; 2014; 90(2):81-8. PubMed ID: 25196354
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
[TBL] [Abstract][Full Text] [Related]
7. A recurrent ABCC2 p.G693R mutation resulting in loss of function of MRP2 and hyperbilirubinemia in Dubin-Johnson syndrome in China.
Wu L; Li Y; Song Y; Zhou D; Jia S; Xu A; Zhang W; You H; Jia J; Huang J; Ou X
Orphanet J Rare Dis; 2020 Mar; 15(1):74. PubMed ID: 32183854
[TBL] [Abstract][Full Text] [Related]
8. Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancer.
Hoblinger A; Grunhage F; Sauerbruch T; Lammert F
Digestion; 2009; 80(1):36-9. PubMed ID: 19451719
[TBL] [Abstract][Full Text] [Related]
9. Influence of ATP-binding cassette polymorphisms on neurological outcome after traumatic brain injury.
Cousar JL; Conley YP; Willyerd FA; Sarnaik AA; Puccio AM; Empey PE; Kochanek PM; Bell MJ; Okonkwo DO; Clark RS
Neurocrit Care; 2013 Oct; 19(2):192-8. PubMed ID: 23896815
[TBL] [Abstract][Full Text] [Related]
10. Association of
Chen L; Zheng C; Hao M; Gao P; Zhao M; Cao Y; Ma L
Front Pharmacol; 2022; 13():889473. PubMed ID: 36278153
[No Abstract] [Full Text] [Related]
11. A systematic review and meta-analysis of the association of ABCC2/ABCG2 polymorphisms with antiepileptic drug responses in epileptic patients.
Zan X; Yue G; Hao Y; Sima X
Epilepsy Res; 2021 Sep; 175():106678. PubMed ID: 34087576
[TBL] [Abstract][Full Text] [Related]
12. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver.
Meier Y; Pauli-Magnus C; Zanger UM; Klein K; Schaeffeler E; Nussler AK; Nussler N; Eichelbaum M; Meier PJ; Stieger B
Hepatology; 2006 Jul; 44(1):62-74. PubMed ID: 16799996
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Duran G; Cruz R; Aguín S; Barros F; Giráldez JM; Bernárdez B; Zarra I; López-López R; Carracedo Á; Lamas MJ
Cancer Chemother Pharmacol; 2021 Nov; 88(5):813-823. PubMed ID: 34309735
[TBL] [Abstract][Full Text] [Related]
14. Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China.
Zhao T; Li HJ; Zhang HL; Feng J; Yu J; Wang TT; Sun Y; Yu LH
Ther Drug Monit; 2023 Feb; 45(1):117-125. PubMed ID: 36253887
[TBL] [Abstract][Full Text] [Related]
15. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms of MRP2 (ABCC2) are associated with susceptibility to nonalcoholic fatty liver disease.
Sookoian S; Castaño G; Gianotti TF; Gemma C; Pirola CJ
J Nutr Biochem; 2009 Oct; 20(10):765-70. PubMed ID: 18926681
[TBL] [Abstract][Full Text] [Related]
17. ABCC2 c.-24 C>T single-nucleotide polymorphism was associated with the pharmacokinetic variability of deferasirox in Chinese subjects.
Cao K; Ren G; Lu C; Wang Y; Tan Y; Zhou J; Zhang Y; Lu Y; Li N; Chen X; Zhao D
Eur J Clin Pharmacol; 2020 Jan; 76(1):51-59. PubMed ID: 31677118
[TBL] [Abstract][Full Text] [Related]
18. New ABCC2 rs3740066 and rs2273697 Polymorphisms Identified in a Healthy Colombian Cohort.
Bustos-Cruz RH; Martínez LR; García JC; Barreto GE; Suárez F
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30018187
[TBL] [Abstract][Full Text] [Related]
19. Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract.
Nakano T; Sekine S; Ito K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(11):G807-17. PubMed ID: 24091598
[TBL] [Abstract][Full Text] [Related]
20. Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.
Haenisch S; Zimmermann U; Dazert E; Wruck CJ; Dazert P; Siegmund W; Kroemer HK; Warzok RW; Cascorbi I
Pharmacogenomics J; 2007 Feb; 7(1):56-65. PubMed ID: 16788565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
